Americans should get back to the philosophy of understanding that the country won't do well until everybody does well.
As Jenn Powell's MS progression continues, she's had to make the difficult decision to step away from the stress of full-time ...
A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalized treatment can slow or even ...
OMAHA, Neb. (WOWT/Gray News) - A Nebraska woman has become the first patient in the world to undergo a groundbreaking new treatment for multiple sclerosis. Seven years ago, Jan Janisch-Hanzlik began ...
A biology teacher has been given a “gamechanger” therapy to treat multiple sclerosis (MS), becoming the first patient in the UK to receive the procedure. Experts believe the CAR T-cell treatment will ...
Real-world discontinuation rates of ocrelizumab are low, similar to pivotal trials, with rates between 3.2% and 4.1% for RRMS and PPMS. Side effects are the most common reason for discontinuation, ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results